COVID-19 / Coronavirus

I-Mab Announces First Two Patients Dosed in U.S. Phase 2 Combination Trial of Uliledlimab with Atezolizumab in Patients with Selected Advanced Solid Tumors

2021-12-03 21:00 607

SHANGHAI and GAITHERSBURG, Md., Dec. 3, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first two patients have been dosed in the U.S. p...

MKD to harness Industrial IOT capabilities

2021-12-03 20:30 690

SHANGHAI, Dec. 3, 2021 /PRNewswire/ -- Dr. Dongliang Chang, Chairman of the Board of Directors of Molecular Data Inc. (NASDAQ:MKD), has been appointed the Dean of the Institute for Industrial Internet of Things(IOT) Industry Research, Hangzhou Institute for Advanced Studies, UCAS (hereinafter ref...

Mongolian Government To Build On COVID-19 Vaccine And Booster Success

2021-12-03 15:00 717

* Mongolia secures nearly 70% vaccination rates and an overall casualty rate of only 0.3% * Successes against COVID-19 position country well for ambitious and progressive reforms as part of government's Vision 2050 agenda ULAANBAATAR, Mongolia, Dec. 3, 2021 /PRNewswire/ -- Mongolia is prepari...

Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam

2021-12-03 14:24 762

* Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE™ inVietnam * The agreement includes a minimum commitment of 1 million units in the first year * VIRALEZE™ is scheduled to be officially launched in Vietnam today, following its registration for sale this week ...

Rayence's Low-Dose Detector "GreenON" Receives Critical Acclaim at RSNA 2021

2021-12-02 21:30 745

SEOUL, South Korea, Dec. 2, 2021 /PRNewswire/ -- Rayence( ) reported that its low-dose detectors "GreenON" received critical acclaim at the RSNA(Radiological Society ofNorth America) 2021.

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

2021-12-02 21:00 1235

HONG KONG, Dec. 2, 2021 /PRNewswire/ -- The Centre for Gut Microbiota Research of the Faculty of Medicine at TheChinese University of Hong Kong (CU Medicine) is among the first in the world to discover that germs in our gut (gut microbiota) modulate our immunity and disease severity in COVID-19. ...

DoctorOnCall Partners Up With Qualitas Group to Bolster Booster Vaccination Drive

2021-12-02 15:12 819

KUALA LUMPUR, Malaysia, Dec. 2, 2021 /PRNewswire/ -- DoctorOnCall, Malaysia's first and largest digital health platform today announced its partnership with Qualitas Medical Group to form a collaborative alliance to extendCOVID-19 vaccination to the population who are yet to receive it, including...

Cue Health Receives Singapore HSA Authorization for its Molecular COVID-19 Test for Self-Testing

2021-12-02 02:28 878

- The Cue COVID-19 Test was authorized for self-testing by the Singapore Health Sciences Authority (HSA) through its Pandemic Special Access Route (PSAR) - The HSA authorization of the Cue COVID-19 Test is for home use in both symptomatic and asymptomatic users, ages 2 years and up - Cue Health ...

Havas Health & You Appoints Tara Stewart As Managing Director, Havas Health CX

2021-12-01 23:15 952

NEW YORK, Dec. 1, 2021 /PRNewswire/ -- To help health companies navigate the immense shifts in patient and provider behavior around medical technologies and therapies brought about by COVID-19, Havas Health & You today announced that Tara Stewart, longtime pharmaceutical executive, will join HHCX ...

When and How to Screen for Colorectal Cancer? New NCCN Patient Guideline Explains Latest Timing and Approaches

2021-12-01 21:37 882

PLYMOUTH MEETING, Pa., Dec. 1, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Colorectal Cancer Screening. Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer inthe United States, with...

VIRALEZE™ antiviral nasal spray registered in Vietnam with launch to follow this week

2021-12-01 16:40 723

MELBOURNE, Australia, Dec. 1, 2021 /PRNewswire/ -- Australian biotech company Starpharma  today announced that its broad spectrum antiviral nasal spray, VIRALEZE™, has been registered for sale inVietnam, with the product scheduled to launch inVietnam this week. VIRALEZE™...

GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

2021-12-01 12:03 1271

TOKYO and SINGAPORE, Dec. 1, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture,Japan, today announces a strategic agreement for joint research a...

Stay Hydrated in a Sustainable Way @Dorsett Wanchai

2021-12-01 10:00 840

HONG KONG, Dec. 1, 2021 /PRNewswire/ -- We hear you, Earth. In Hong Kong, the amount of single-use plastic containers reached over100M every week in 2020, doubling the figure before COVID-19.[i] Embracing its #DorsettCares promise to deliver guests sustainable positive impacts, Dorsett Wanchai, H...

Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant

2021-12-01 08:00 888

SHANGHAI and CALGARY, Canada, Dec. 1, 2021 /PRNewswire/ -- Everest Medicines and Providence Therapeutics ("Providence") jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifically targeting the new Omicron variant. Scientists from the two com...

EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants

2021-12-01 05:22 710

PROVIDENCE, R.I., Dec. 1, 2021 /PRNewswire/ -- Today EpiVax, Inc. ("EpiVax") confirmed that the company'sEPV-CoV-19 vaccine epitopes are 98.2% conserved in the new Omicron SARS-CoV-2 variant. EpiVax and EpiVax Therapeutics, Inc. ("EVT") are also affirming commitment to move the novel T cell epito...

Invetech Wins International Health Award at Australian Export Awards

2021-12-01 00:00 858

MELBOURNE, Australia, Dec. 1, 2021 /PRNewswire/ -- Invetech, an end-to-end commercialization partner to world's foremost therapeutic and diagnostic companies, has won the Australian International Health Award at the59th  Australian Export Awards on 25 November.

Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease

2021-11-30 21:30 612

SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the signing of a Memorandum of Understanding ("MOU") with Institut Pasteur Korea ("IPK"), the infectious disease-focused research...

Angel Yeast Enters Comprehensive Health Industry with New Joint Venture Project

2021-11-30 21:06 924

YICHANG, China, Nov. 30, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast ")( ), a listed high-tech yeast company inChina, has announced that it has signed an agreement with two prominent biomedical companies to establish a new joint venture, Hube...

George Clinical Applauded by Frost & Sullivan for Improving Clinical Trial Efficiency and Patient-centricity through Impactful, Strategic Partnerships

2021-11-30 20:33 718

Innovation through impactful, strategic partnerships improves efficiency and delivers scientific leadership and patient-centricity in clinical trials execution. SANTA CLARA, Calif., Nov. 30, 2021 /PRNewswire/ -- Based on its recent analysis of theAsia-Pacific clinical contract research organizat...

Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant

2021-11-30 19:25 741

SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530),  South Korea's leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is capable of detecting the Omicron's unique pattern of mutations. The well-established PCR-based test recogni...

12345 ... 163